These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 23154540

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A, Sultan SS, Mogazi K, Elsammak MY.
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [Abstract] [Full Text] [Related]

  • 3. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.
    Paniagua R, Ventura MD, Avila-Díaz M, Hinojosa-Heredia H, Méndez-Durán A, Cueto-Manzano A, Cisneros A, Ramos A, Madonia-Juseino C, Belio-Caro F, García-Contreras F, Trinidad-Ramos P, Vázquez R, Ilabaca B, Alcántara G, Amato D.
    Nephrol Dial Transplant; 2010 Feb; 25(2):551-7. PubMed ID: 19679559
    [Abstract] [Full Text] [Related]

  • 4. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
    Racek J, Králová H, Trefil L, Rajdl D, Eiselt J.
    Nephron Clin Pract; 2006 Feb; 103(4):c162-72. PubMed ID: 16645318
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I, Belhadj R, Mohseni A, Bazdeh L, Drissa H, Elyounsi F, Abdallah TB, Abdelmoula J, Kheder A.
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [Abstract] [Full Text] [Related]

  • 7. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
    Bargnoux AS, Klouche K, Fareh J, Barazer I, Villard-Saussine S, Dupuy AM, Leray-Moragues H, Giuliani I, Canaud B, Cristol JP.
    Clin Chem Lab Med; 2008 Mar; 46(7):1019-24. PubMed ID: 18624622
    [Abstract] [Full Text] [Related]

  • 8. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
    Pimenta J, Sampaio F, Martins P, Carvalho B, Rocha-Gonçalves F, Ferreira A, Bettencourt P.
    Nephron Clin Pract; 2009 Mar; 111(3):c182-8. PubMed ID: 19194108
    [Abstract] [Full Text] [Related]

  • 9. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis.
    Nakatani T, Naganuma T, Masuda C, Uchida J, Sugimura T, Sugimura K.
    Int J Mol Med; 2002 Oct; 10(4):457-61. PubMed ID: 12239593
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [Abstract] [Full Text] [Related]

  • 11. Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients.
    Lee JA, Kim DH, Yoo SJ, Oh DJ, Yu SH, Kang ET.
    Perit Dial Int; 2006 Apr; 26(3):360-5. PubMed ID: 16722030
    [Abstract] [Full Text] [Related]

  • 12. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
    Choi SY, Lee JE, Jang EH, Kim MO, Baek H, Ki CS, Park SW, Kim DJ, Huh WS, Oh HY, Kim YG.
    Nephron Clin Pract; 2008 Apr; 110(2):c93-100. PubMed ID: 18815449
    [Abstract] [Full Text] [Related]

  • 13. Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients.
    Takeda K, Nakamoto M, Baba M, Tanaka T, Yasunaga C, Nishihara G, Matsuo K, Urabe M.
    Clin Nephrol; 1998 May; 49(5):308-12. PubMed ID: 9617495
    [Abstract] [Full Text] [Related]

  • 14. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
    Guo Q, Bárány P, Qureshi AR, Snaedal S, Heimburger O, Stenvinkel P, Lindholm B, Axelsson J.
    Am J Nephrol; 2009 May; 29(6):516-23. PubMed ID: 19077418
    [Abstract] [Full Text] [Related]

  • 15. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship.
    Takase H, Dohi Y.
    Eur J Clin Invest; 2014 May; 44(3):303-8. PubMed ID: 24372567
    [Abstract] [Full Text] [Related]

  • 16. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE.
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [Abstract] [Full Text] [Related]

  • 17. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
    Ribeiro HB, Urena M, Le Ven F, Nombela-Franco L, Allende R, Clavel MA, Dahou A, Côté M, Laflamme J, Laflamme L, DeLarochellière H, DeLarochellière R, Doyle D, Dumont E, Bergeron S, Pibarot P, Rodés-Cabau J.
    Am J Cardiol; 2014 Mar 01; 113(5):851-9. PubMed ID: 24528616
    [Abstract] [Full Text] [Related]

  • 18. Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients.
    Leowattana W, Ong-Ajyooth L, Taruangsri P, Pokum S.
    J Med Assoc Thai; 2003 May 01; 86 Suppl 1():S52-8. PubMed ID: 12866769
    [Abstract] [Full Text] [Related]

  • 19. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S, Maeder MT, Nietlispach F, Rickli H, Estlinbaum W, Erne P, Rickenbacher P, Peter M, Pfisterer MP, Brunner-La Rocca HP, TIME-CHF Investigators.
    Circ Heart Fail; 2014 Jan 01; 7(1):131-9. PubMed ID: 24352403
    [Abstract] [Full Text] [Related]

  • 20. Assessment and comparison of acute cardiac toxicity during high-dose cyclophosphamide and high-dose etoposide stem cell mobilization regimens with N-terminal pro-B-type natriuretic peptide.
    Ozkan HA, Bal C, Gulbas Z.
    Transfus Apher Sci; 2014 Feb 01; 50(1):46-52. PubMed ID: 24382557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.